Active — Not RecruitingNot Applicable

Precise and Objective Identification of Bertolotti Syndrome Using Novel Kinematic Biomarkers

United States40 participantsStarted 2024-01-17

Plain-language summary

The purpose of this study is to collect lumbar rotations, velocity, and accelerations, along with pain scores using a novel dynamic VAS device, from twenty (20) Bertolotti Syndrome patients and twenty (20) non-Bertolotti low back pain patients during range-of-motion tasks. The assessments will be analyzed to determine the differences in kinematics and continuous pain scores between Bertolotti patients and non-Bertolotti low back pain patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Lower Back Pain Cohort * Positive diagnosis of sacroiliac pain or lumbosacral facet arthritis pain * Age ≥ 18 years Bertolotti's Syndrome Cohort * Positive diagnosis of Bertolotti's Syndrome * Age ≥ 18 years * Positive imaging for Bertolotti's Syndrome * Previous analgesic injection results Exclusion Criteria: Lower Back Pain Cohort * History of spinal deformity, previous spinal surgeries, spinal infections * Pregnant women Bertolotti's Syndrome Cohort * History of spinal deformity, previous spinal surgeries, spinal infections * Pregnant women

What they're measuring

To identify Bertolotti's Syndrome-specific kinematic biomarkers using collected patient kinematic and real-time VAS data from range-of-motion tasks.

Timeframe: 2025

Trial details

NCT IDNCT06225583

SponsorThe Cleveland Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Bertolotti's Syndrome trials